Agriculture›
Apparel and fashion accessories›
Construction & real estate›💡Electronic & Electrical›🍎Food & Beverages›🛋️Home furnishing & supplies›⚗️Industrial goods & chemical›🪨Minerals & metals›📦Miscellaneous›
Agriculture›
Apparel and fashion accessories›
Construction & real estate›💡Electronic & Electrical›🍎Food & Beverages›🛋️Home furnishing & supplies›⚗️Industrial goods & chemical›🪨Minerals & metals›📦Miscellaneous›

MastoCheck is a blood test that can easily screen for breast cancer at an early stage. Breast cancer is diagnosed early by substituting the quantitative values of three types of protein biomarkers in the blood, which are closely related to breast cancer, into a unique, patented algorithm. An innovative and convenient test method that detects early breast cancer with an accuracy of 92% (based on the patent) by using only a very small amount of blood. Bertis has developed multiple markers that can detect early breast cancer with an accuracy of 92% through identification of multiple proteins that are expressed sensitively in early-stage breast cancer and combination of certain proteins that demonstrated high accuracy and reproducibility among these combinations. DEVELOPMENT PROCESS: - MASTOCHECK was developed by a team led by Professor Dong-Young Noh, a world-renowned authority on breast cancer, of Seoul National University. - After analyzing approximately 600,000 proteins and selecting 3 markers exhibiting optimal accuracy, the highest accuracy was obtained by adding Bertis�¢?? own algorithm that enhances accuracy. - After several years of repeated validation work, a medical device product license was obtained from the MFDS in January 2019. To date (as of September 2023), MASTOCHECK has been introduced to about 400 hospitals and screening institutions nationwide, with priority given to large screening institutions.
| HS Code | 3822.90 |
| Material | Diagnostic Reagent Composition: Protein Biomarkers, Antibodies, ELISA Substrate Solution, Calibrator Controls, Wash Buffer |
| Product Type | Quantitative ELISA Diagnostic Kit for Breast Cancer Screening |
| Target Biomarkers | 3 Protein Tumor Markers (CA 15-3, CEA, and Additional Breast Cancer Associated Proteins) |
| Sample Type | Serum or Plasma (venous blood) |
| Test Format | 96-well Microplate ELISA (quantitative) |
| Sensitivity / Detection Range | High sensitivity; specific detection range per biomarker indicated in product insert |
| Intended Use | Early-stage breast cancer screening, disease monitoring, and recurrence detection in clinical laboratory settings |
| Storage / Stability | 2-8°C (refrigerated); stable until expiry date on packaging |
| Packaging | 96 tests per kit box; individual sealed strips available; includes calibrators, controls, and reagents |
| Regulatory Classification | In Vitro Diagnostic (IVD) Medical Device; CE / FDA cleared variants available |
| Shelf Life | 12 months from manufacture date (minimum) |
| Origin | Product of Record; contact manufacturer for country of origin details |
MastoCheck is a quantitative in vitro diagnostic kit designed for early breast cancer screening through detection of specific protein biomarkers in blood serum or plasma samples. Suitable for clinical pathology laboratories, oncology departments, and hospital diagnostic centers, this kit supports high-throughput screening workflows with standard ELISA instrumentation. As a regulated Class II/III medical device, it requires proper cold-chain logistics and is classified under standard diagnostic reagent HS codes for international trade clearance.
| Business Type | Supplier |
| Year Established | Recently Joined |
| Employees | Contact Supplier |
| Annual Revenue | Contact Supplier |
| Main Products | View Products Tab |
| Major Markets | Global |
| Response Time | <4h |
| Response Rate | New Supplier |
MASTOCHECK Breast Cancer Early Diagnosis is offered by Bertis Inc., a Supplier based in South Korea (Republic Of Korea), in wholesale quantities for importers, distributors, and trade buyers. Contact the supplier to request pricing, minimum order quantity, and shipping terms for your destination.
When importing MASTOCHECK Breast Cancer, confirm trade terms such as FOB or CIF, packaging, and any certification or documentation you need directly with the supplier before placing a bulk order.
Active buying requirements from importers looking for Similar products
Compare alternatives, find similar products and connect with verified suppliers
When sourcing Mastocheck Breast Cancer Early Diagnosis for your business, securing the right balance of quality and cost is essential. Bertis Inc., a verified supplier based in South Korea (Republic Of Korea), offers this product with key specifications including Quantitative ELISA Diagnostic Kit for Breast Cancer Screening, 3 Protein Tumor Markers (CA 15-3, CEA, and Additional Breast Cancer Associated Proteins), and Serum or Plasma (venous blood). By purchasing directly from the manufacturer or authorized exporter, buyers can negotiate favorable FOB prices starting at $8035096./Unit and manage bulk orders with a minimum order quantity (MOQ) of 1 Unit. This product is actively traded under HS Code 3822.90, making it a staple in the Diagnostic Kits sector with strong demand from importing countries worldwide.
Importing Mastocheck Breast Cancer requires careful attention to shipping logistics, customs compliance, and secure payment terms. Bertis Inc. offers flexible shipping options such as Full Container Load (FCL) or Less than Container Load (LCL) via sea freight. To ensure a smooth transaction, buyers should verify import duties for HS Code 3822.90 in their destination country. Common payment methods for international B2B transactions include Letter of Credit (L/C), Telegraphic Transfer (T/T), and Documents against Payment (D/P). All transactions and RFQs are facilitated through EximNext, a leading import export marketplace designed to make cross-border trade secure and efficient.
Finding trustworthy partners is the foundation of successful importing. The supplier of this Mastocheck Breast Cancer has been verified on our platform. Whether you are a distributor, wholesaler, or procurement manager, you can request a free quotation, ask for product samples, and finalize your bulk purchase with confidence. EximNext hosts thousands of verified manufacturers and exporters across 200+ countries. Explore similar products in the Diagnostic Kits category and connect with top-tier exporters on our comprehensive online B2B marketplace. Start your sourcing journey today.
Importing Mastocheck Breast Cancer requires careful attention to shipping logistics, customs compliance, and secure payment terms. Common shipping options include Full Container Load (FCL) or Less than Container Load (LCL) via sea freight. Buyers should verify import duties for HS Code 3822.90 in their destination country. Common payment methods include Letter of Credit (L/C), Telegraphic Transfer (T/T), and Documents against Payment (D/P).
The current listed wholesale price for Mastocheck Breast Cancer Early Diagnosis from Bertis Inc. is $8035096./Unit on FOB terms from South Korea (Republic Of Korea). Prices may vary depending on order volume, packaging, and destination. For the most accurate bulk quote, send a direct RFQ to Bertis Inc. through EximNext.
The supplier, Bertis Inc., has set a Minimum Order Quantity (MOQ) of 1 Unit for Mastocheck Breast Cancer. For sample requests or smaller trial orders, contact the supplier directly through our platform's inquiry system.
For international shipping and customs clearance, Mastocheck Breast Cancer Early Diagnosis is classified under HS Code 3822.90. Buyers should verify their local customs regulations to determine applicable import duties and taxes for this classification.
To import Mastocheck Breast Cancer from South Korea (Republic Of Korea), negotiate shipping terms (FOB, CIF, or EXW) directly with Bertis Inc.. Ensure you have the necessary import licenses for Diagnostic Kits products in your destination country.
Yes, Bertis Inc. is a verified supplier on EximNext. You can view their complete company profile, business registration details, certifications, and export history before placing a bulk order.
The key specifications for Mastocheck Breast Cancer Early Diagnosis supplied by Bertis Inc. include Quantitative ELISA Diagnostic Kit for Breast Cancer Screening, 3 Protein Tumor Markers (CA 15-3, CEA, and Additional Breast Cancer Associated Proteins), and Serum or Plasma (venous blood). For a complete technical data sheet or Certificate of Analysis (COA), send an inquiry directly to the supplier through EximNext.
Bertis Inc. offers Mastocheck Breast Cancer with standard export packaging. Custom packaging, private labeling, and OEM/ODM options may also be available for large wholesale orders.
Mastocheck Breast Cancer is actively imported by buyers worldwide. Request a destination-specific CIF or CFR quote from Bertis Inc. through our platform.
Bertis Inc. maintains international quality certifications. These ensure that the Mastocheck Breast Cancer meets international quality, safety, and regulatory standards required for cross-border trade.
Click "Request Quotation" on this product page, specify your required quantity, preferred shipping terms, and destination country. Bertis Inc. will respond with a detailed wholesale quote including FOB pricing, lead time, and payment options.
Common payment methods include Letter of Credit (L/C), Telegraphic Transfer (T/T), Documents against Payment (D/P), and Escrow services. Confirm accepted terms directly with Bertis Inc..
Discover more products in Diagnostic Kits from verified suppliers worldwide.